SLNO is currently covered by 7 analysts with an average price target of $65. This is a potential upside of $11.99 (22.62%) from yesterday's end of day stock price of $53.01.
Soleno Therapeutics's activity chart (see below) currently has 119 price targets and 111 ratings on display. The stock rating distribution of SLNO is 93.75% BUY and 6.25% HOLD.
Analysts' price targets on this stock were met 37.35% of the time, taking 90.5 days on average.
Highest price target for SLNO is $107, Lowest price target is $53, average price target is $65.
Most recent stock forecast was given by from CANTOR FITZGERALD on 19-May-2026. First documented stock forecast 21-Jun-2018.
Currently out of the existing stock ratings of SLNO, 15 are a BUY (93.75%), 1 are a HOLD (6.25%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 19-May-2026
$53
6 months 2 days ago
(19-May-2026)
9/10 (90%)
$0.75 (1.44%)
119
Buy Since 20-Aug-2025
$53
$-0.01 (-0.02%)
$110
7 months 4 days ago
(17-Apr-2026)
1/6 (16.67%)
$0.22 (0.42%)
28
Buy Since 03-Sep-2024
$53
$-0.01 (-0.02%)
$100
7 months 13 days ago
(08-Apr-2026)
5/10 (50%)
$0.4 (0.76%)
105
Buy Since 23-Jun-2025
$53
$-0.01 (-0.02%)
$85
7 months 14 days ago
(07-Apr-2026)
1/7 (14.29%)
$0.65 (1.24%)
38
Buy Since 17-Nov-2025
$60
7 months 14 days ago
(06-Apr-2026)
0/2 (0%)
$18.46 (44.44%)
What is SLNO (Soleno Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on SLNO (Soleno Therapeutics)?
Which analyst has the most public recommendations on SLNO (Soleno Therapeutics)?
Which analyst is the currently most bullish on SLNO (Soleno Therapeutics)?
Which analyst is the currently most reserved on SLNO (Soleno Therapeutics)?